Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects
Clinical Infectious Diseases · 2024-10-15 · 79 (4) · e27-e47
DOI: 10.1093/cid/ciae421 ↗At a glance
Übersichtsarbeit in Clinical Infectious Diseases, published online on 2024-08-28. Written by Minh-Vu H Nguyen and 9 co-authors. Institution: Division of Mycobacterial and Respiratory Infections, Department of Medicine, National Jewish Health, Denver, Colorado, USA. Major MEDLINE topics: Mycobacterium Infections, Nontuberculous, Nontuberculous Mycobacteria. Cited 62 times so far (Crossref); 101 references. Funded by: Lowerre Mycobacterial Research Fellowship.
Abstract (original language)
Nontuberculous mycobacterial pulmonary disease (NTM-PD) is increasing in incidence globally and challenging to manage. The 2020 multisociety treatment guideline and the 2022 consensus recommendations provide comprehensive evidence-based guides to manage pulmonary diseases caused by the most common NTM. However, with >190 different NTM species that may require different multidrug regimens for treatment, the breadth and complexity of NTM-PD remain daunting for both patients and clinicians. In this narrative review, we aim to distill this broad, complex field into principles applicable to most NTM species and highlight important nuances, specifically elaborating on the presentation, diagnosis, principles of patient-centered care, principles of pathogen-directed therapy, and prospects of NTM-PD.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Mycobacterial and Respiratory Infections, Department of Medicine, National Jewish Health, Denver, Colorado, USA.
- Division of Infectious Diseases, Department of Medicine, University of Colorado, Aurora, Colorado, USA.
- Division of Cardiothoracic Surgery, Department of Surgery, University of Colorado, Aurora, Colorado, USA.
- Advanced Diagnostics Laboratories, National Jewish Health, Denver, Colorado, USA.
- Department of Academic Affairs, National Jewish Health, Denver, Colorado, USA.
- Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado, Aurora, Colorado, USA.
ORCID profiles: Minh-Vu H Nguyen
Funding
- Lowerre Mycobacterial Research Fellowship
Cite
APA
Nguyen, M. H., Haas, M. K., Kasperbauer, S. H., Calado Nogueira de Moura, V., Eddy, J. J., Mitchell, J. D., Khare, R., Griffith, D. E., Chan, E. D., & Daley, C. L. (2024). Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects. Clinical Infectious Diseases, 79(4), e27-e47. https://doi.org/10.1093/cid/ciae421
Vancouver
Nguyen MH, Haas MK, Kasperbauer SH, Calado Nogueira de Moura V, Eddy JJ, Mitchell JD, et al. Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects. Clinical Infectious Diseases. 2024;79(4):e27-e47. doi:10.1093/cid/ciae421
BibTeX
@article{Nguyen2024,
author = {Nguyen, Minh-Vu H and Haas, Michelle K and Kasperbauer, Shannon H and Calado Nogueira de Moura, Vinicius and Eddy, Jared J and Mitchell, John D and Khare, Reeti and Griffith, David E and Chan, Edward D and Daley, Charles L},
title = {Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects},
journal = {Clinical Infectious Diseases},
year = {2024},
volume = {79},
number = {4},
pages = {e27--e47},
doi = {10.1093/cid/ciae421}
}
EUVIMED